Search Results for keywords:"section 529 FD

San Joaquin Valley Railroad Co. (SJVR) has filed a notice to continue leasing and operating 101.5 miles of rail lines from Union Pacific Railroad Company (UP). This new lease replaces a previous one from 1994 and includes an interchange commitment. SJVR ensures its revenue won’t exceed the limit for a Class III carrier but admits it currently surpasses $5 million, for which it seeks a waiver on the 60-day labor notice period. This request will be reviewed separately by the Surface Transportation Board, which will set the exemption's effective date.

OmniTRAX Holdings Combined, Inc. and HGS Railway Holdings, Inc., together known as Omni-HGS, have filed a notice to continue controlling the Santa Maria Valley Railroad, LLC (SMVR), which will become a Class III rail carrier. This transaction is part of a plan where SMVR will acquire and operate certain railway lines in California, without connecting to other lines within Omni-HGS's ownership. The transaction is exempt from prior approval requirements because it involves only Class III carriers. Any petitions related to this notice must be submitted to the Surface Transportation Board, and the action is considered exempt from environmental and historical reporting requirements.

The Food and Drug Administration (FDA) is asking for public comments on gathering information related to food additives for animal food. Under the Paperwork Reduction Act, federal agencies must allow 60 days for public comments on such collections. The FDA is revising its information collection efforts to include new guidance related to the safety of pet food under recent amendments. They also explain the estimated time and effort it takes for companies to submit necessary documentation and consult with the FDA on animal food additives.

Norfolk Southern Corporation and Norfolk Southern Railway Company are asking the Surface Transportation Board for permission to take control of the Norfolk & Portsmouth Belt Line Railroad Company. The Board is announcing the suggested schedule for reviewing this proposal and is seeking public feedback on it. The schedule outlines the key deadlines for public comments, application reviews, and final decisions, with the entire process expected to conclude in about 300 days. The Board has also decided that 2023 will be used as the year for evaluating the impact of this acquisition.

The Food and Drug Administration (FDA) is asking for public comments on its data collection efforts related to the Biosimilars User Fee Program, which supports the development of biosimilar drugs. The program, part of the Biologics Price Competition and Innovation Act, helps guide the approval process for biosimilars by allowing companies to pay user fees to the FDA. These fees are collected to ensure the safe and effective development of these drugs. Companies interested in participating should submit comments by March 5, 2025, and can find more information on the FDA's website.

The Surface Transportation Board received a prefiling notification regarding a proposed transaction where Norfolk Southern Corporation and Norfolk Southern Railway Company aim to gain control of Norfolk & Portsmouth Belt Line Railroad Company. After reviewing the February 14, 2025 submission, the Board determined the transaction is "significant" rather than "minor," requiring more detailed information and compliance with different procedures. The Board instructed Norfolk Southern to amend their application, submit a revised procedural schedule by March 21, 2025, and to pay the additional filing fee associated with significant transactions. Additionally, the Board noted concerns from CSX Transportation and the Virginia Port Authority about potential anticompetitive effects.

SRC Railway LLC, a noncarrier company, has announced its plan to lease and operate a 4.25-mile stretch of rail line called the Strasburg Line in Lancaster County, Pennsylvania, from the Strasburg Rail Road Company. This action is part of a related notice that allows SRC to continue to control SRC Railway LLC once it starts functioning as a Class III rail carrier. The company assures that its annual revenue from this operation will not exceed $5 million, keeping it from advancing to a Class I or II rail carrier status. Any challenges to this lease exemption must be submitted by January 12, 2021, with the exemption's effective date being January 20, 2021.

Dakota Northern Railroad, Inc. (DN), a small Class III railroad, plans to lease and operate two rail lines from BNSF Railway Company in North Dakota. The rail lines extend 59.84 miles near Grafton, Walhalla, and St. Thomas, ND. DN is continuing an existing lease and expects to finalize the new lease terms before the current one expires on January 31, 2021, without any interchange commitments. The Surface Transportation Board notes that the transaction may proceed from January 29, 2021, and it won't lead to DN becoming a larger Class I or II rail carrier.

The Bureau of Industry and Security, part of the U.S. Department of Commerce, is updating the Export Administration Regulations to impose new restrictions on certain biotechnology equipment. This interim final rule targets equipment, such as flow cytometers and mass spectrometers, used in advanced biotechnology, which could pose national security risks if misused. These regulations come into effect on January 16, 2025, and they also invite the public to comment on the new measures by March 17, 2025. The rule aims to prevent these technologies from being used in ways that could threaten U.S. security while still allowing for their beneficial use in fields like health and environmental science.

The Food and Drug Administration (FDA) has announced that certain Food Contact Notifications (FCNs) are no longer effective because some manufacturers stopped using the listed substances for food contact in the U.S. The FDA is following a set process that allows them to determine when an FCN is no longer in use. They expect all remaining stocks of these substances, which were last produced or supplied before January 6, 2025, to be used up by June 30, 2025, as a measure to protect public health. The FDA updated its inventory of effective and no longer effective FCNs on their website.